Speaker Profile
Ph.D., Co-Founder and CEO, Scribe Tx
Biography
Benjamin Oakes is co-founder and CEO of Scribe Therapeutics, a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic intervention. Previously, Dr. Oakes was an Innovative Genomics Institute Entrepreneurial Fellow, received a Ph.D. in Molecular and Cellular Biology from the University of California, Berkeley, and worked in the lab of Nobel Laureate and CRISPR co-inventor Jennifer Doudna. Dr. Oakes and his Scribe team pioneered a CRISPR by Design™ approach to engineering bacterial immune systems into genome editing and epigenetic silencing tools that are optimized for activity, specificity, and deliverability and designed to enable standard of care treatments for patients with highly prevalent diseases, starting with cardiometabolic disease.
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
